Institute of Biomedical Research Corp 最近的每股盈餘為 $, $ 的預期。
Institute of Biomedical Research Corp MRES 上一季度的收入表現如何?
Institute of Biomedical Research Corp 上一季度的收入為 $
Institute of Biomedical Research Corp 的收入預期是多少?
根據 位華爾街分析師的預測,Institute of Biomedical Research Corp 的收入預期範圍從 $ 到 $
Institute of Biomedical Research Corp 的盈利品質評分是多少?
Institute of Biomedical Research Corp 的盈利品質評分為 /。該評分基於盈利能力、增長、現金生成與資本分配以及槓桿四個維度。
Institute of Biomedical Research Corp 何時發布財報?
Institute of Biomedical Research Corp 的下一份財報預計在 發布
Institute of Biomedical Research Corp 的預期收益是多少?
根據華爾街分析師的預測,Institute of Biomedical Research Corp 的預期收益為 $
Institute of Biomedical Research Corp 是否超出收益預期?
Institute of Biomedical Research Corp 最近的收益為 $, 預期。
關鍵數據
前收市價
$0.0014
開盤價
$0.002
當日範圍
$0.002 - $0.002
52週區間
$0.0007 - $0.0241
交易量
940.0K
平均成交量
812.7K
股息收益率
--
每股盈餘 (TTM)
--
市值
$4.7M
什麼是 MRES?
Institute of BioMedical Research Corp. engages in research and development, quality control and standardization of pharmaceuticals, cosmetics and food products. The company is headquartered in Niksic, Niksic. The company went IPO on 2000-10-27. The firm's services include scientific research and biomedical services, such as research and development, quality control, standardization of pharmaceuticals, cosmetics and food products. The firm also provides long-term biomedical and environmental research projects, develops new diagnostic biomedical technologies and experimental medical treatments. The firm's products include Aerosan, MicrobEX, Microbicidal Towels KleNET, OralNet, Oral Ocean Power and Purilair. The company offers electro medical devices, such as BioMed 2000 XT with Timer, BioStim INF, QuadStar Elite, QuadStar II, Pain Gone piezo-electric pain relief and Portable Ultra Sound Device. The company offers various services, including quality control services, regulatory services, healthcare services, environmental analyses, building decontamination, and environmental protection and management.